Description

BSE lists 3,71,000 new equity shares of Gujarat Terce Laboratories Limited (Scrip Code 524314) issued to promoters on a preferential basis, effective February 25, 2026. Shares are locked in until June 16, 2027.

Summary

BSE has listed 3,71,000 new equity shares of Gujarat Terce Laboratories Limited (Scrip Code: 524314, ISIN: INE499G01013) issued to promoters on a preferential basis at an issue price of Rs. 37.70 per share (face value Rs. 10 + premium Rs. 27.70). These shares are permitted to trade on the Exchange with effect from Wednesday, February 25, 2026, and rank pari-passu with the existing equity shares of the company.

Key Points

  • Shares listed: 3,71,000 equity shares of Rs. 10/- face value each
  • Issue price: Rs. 37.70/- per share (Rs. 10 face value + Rs. 27.70 premium)
  • Allotment type: Preferential basis to promoters
  • Distribution numbers: 74,20,301 to 77,91,300
  • Date of allotment: December 16, 2025
  • Trading commencement: February 25, 2026
  • ISIN: INE499G01013
  • All newly listed shares are subject to lock-in until June 16, 2027

Regulatory Changes

No regulatory changes. This is a standard listing notification following completion of a preferential allotment to promoters under applicable SEBI regulations.

Compliance Requirements

  • Trading members are informed that the new securities are listed and permitted to trade from February 25, 2026
  • The lock-in restriction on all 3,71,000 shares must be observed until June 16, 2027; these shares cannot be traded or transferred during the lock-in period
  • Shares rank pari-passu with existing equity shares for all corporate action purposes

Important Dates

  • Date of allotment: December 16, 2025
  • Listing / trading commencement date: February 25, 2026
  • Lock-in expiry date: June 16, 2027

Impact Assessment

The addition of 3,71,000 shares represents a minor increase in the total share capital of Gujarat Terce Laboratories Limited. Since the shares are allotted to promoters and are locked in until June 2027, there is no immediate dilution impact or additional free-float in the near term. Market impact is minimal and confined to the specific scrip (BSE: 524314). Retail investors and trading members should note the lock-in restriction to avoid any settlement issues involving these specific distribution numbers.

Impact Justification

Routine listing of preferential allotment shares to promoters for a small-cap company; limited market-wide impact. Lock-in until mid-2027 further reduces near-term trading impact.